Loading...

Gaia Grow Corp.

GAIA.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.01
CA$0.00(0.00%)

Gaia Grow Corp. (GAIA.CN) Stock Competitors & Peer Comparison

See (GAIA.CN) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
GAIA.CNCA$0.01+0.00%177.2K-0.01-CA$0.72N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
BHC.TOCA$8.17-7.68%3B-51.03-CA$0.16N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
GTII.CNCA$8.18-1.09%1.9B28.21CA$0.29N/A
CURA.TOCA$1.89-2.58%1.4B-4.20-CA$0.45N/A
TRUL.CNCA$6.02-7.38%1.1B-5.57-CA$1.08N/A
CRON.TOCA$2.74-0.72%1.1B14.39CA$0.19N/A
TLRY.TOCA$0.79-8.14%869.4M-0.23-CA$3.38N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

GAIA.CN vs CURA.CN Comparison August 2025

GAIA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GAIA.CN stands at 177.2K. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, GAIA.CN is priced at CA$0.01, while CURA.CN trades at CA$5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GAIA.CN currently has a P/E ratio of -0.01, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, GAIA.CN's ROE is +0.00%, compared to CURA.CN's ROE of -0.25%. Regarding short-term risk, GAIA.CN is less volatile compared to CURA.CN. This indicates potentially lower risk in terms of short-term price fluctuations for GAIA.CN.Check CURA.CN's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;